We’re proud to be a sponsor of ESGCT 2025, the premier European meeting for gene and cell therapy professionals, bringing together innovators, researchers, and industry leaders to share breakthroughs and advance the field.
Book a Meeting: Schedule time with our business development & licensing team to discuss how our CDMO services can support your programs, from development to clinical delivery.
Visit Us at Booth A14: Stop by to meet our team, learn about our services, and explore how we can help accelerate your projects.
Poster Presentations: We’ll be showcasing our latest research through poster presentations below:
Wednesday, October 8, 2025 | 14:00 – 15:30:
- Development and Scale Up of Next Generation Batch Process Demonstrating Increased Productivity and Enhanced Purity (P0825): Oliver Goodyear PhD, Principal Scientist & Group Lead, Innovation
- The TetraVecta™ System: Optimisation and Exemplification of OXB’s Next Generation Lentiviral Vector (P0819): Laura Devlin, PhD, Scientist IV
Thursday, October 8, 2025 | 14:00 – 15:30:
- What’s Upstream of Downstream Matters: Utilising High-Efficiency Secreted Nuclease (SecNuc™ Enzyme) and Transgene Repression (TRiP System™) to Improve rAAV Production (P0888): Alissa Bray, Group Lead, DNA Vector Innovation
We look forward to connecting with you at ESGCT and sharing insights that drive progress in gene and cell therapy.